Finance

Lists
4543:TYO
Terumo Corp
2 283,50 JP¥
+1,78%
(+40,00) 1D
5 հոկ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4543...
Open
2 277 JP¥
High
2 298 JP¥
Low
2 264 JP¥
Mkt. cap
3,38 տրլն
Avg. vol.
4,86 մլն
Volume
5,51 մլն
Dividend
1,31%
Quarterly dividend
7 JP¥
Ex-dividend date
29 սեպ, 2026 թ.
P/E ratio
20,48
52-wk high
2 689 JP¥
52-wk low
1 900 JP¥
EPS
111 JP¥
Shares outstanding
370,59 մլն
No. of employees
31 հզր
Open
2 277 JP¥
High
2 298 JP¥
Low
2 264 JP¥
Mkt. cap
3,38 տրլն
Avg. vol.
4,86 մլն
Volume
5,51 մլն
Dividend
1,31%
Quarterly dividend
7 JP¥
Ex-dividend date
29 սեպ, 2026 թ.
P/E ratio
20,48
52-wk high
2 689 JP¥
52-wk low
1 900 JP¥
EPS
111 JP¥
Shares outstanding
370,59 մլն
No. of employees
31 հզր
News stories
From web sources and news partners
Profile
Terumo Corporation was founded in 1921 as Red Line Thermometer Corporation by a group of medical scientists led by Dr. Kitasato Shibasaburō to produce medical thermometers in Japan. The company's first product was "Jintan Taionkei", the first Japanese-made thermometer available for sale, and it has since expanded into a medical devices manufacturer, producing medical disposables, cardiovascular systems and diabetes care products. In 1971, Terumo opened its first overseas office in the United States. Since then, the company has established subsidiaries in Europe, South America, China, India, Philippines, Vietnam, Thailand, Australia and México. The company later expanded its product range to include coronary stents and catheters, and acquired, among others, the cardiovascular specialty companies Vascutek and Microvention in 2002 and 2006 respectively. Wikipedia
About Terumo Corp
CEO-
Employees31,2 հզր
Founded17 սեպ, 1921 թ.
HeadquartersՍիբույա, Տոկիո, Ճապոնիա
Sector-
Last report
07 օգս, 2026 թ.
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
311,81 մլրդ / 299,25 մլրդ
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
274,96 մլրդ
296,63 մլրդ
300,32 մլրդ
311,81 մլրդ
Cost of goods sold
127,97 մլրդ
143,44 մլրդ
149,06 մլրդ
133,27 մլրդ
Cost of revenue
127,97 մլրդ
143,44 մլրդ
149,06 մլրդ
133,27 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
97,88 մլրդ
105,26 մլրդ
107,66 մլրդ
109,70 մլրդ
Operating expense
101,90 մլրդ
109,31 մլրդ
98,62 մլրդ
89,06 մլրդ
Total operating expenses
229,87 մլրդ
252,74 մլրդ
247,68 մլրդ
222,33 մլրդ
Operating income
45,10 մլրդ
43,88 մլրդ
52,64 մլրդ
89,48 մլրդ
Other non operating income
-1,00 մլն
2,00 մլն
-409,00 մլն
-4,00 մլն
EBT including unusual items
45,95 մլրդ
45,38 մլրդ
31,66 մլրդ
90,32 մլրդ
EBT excluding unusual items
45,95 մլրդ
45,38 մլրդ
52,86 մլրդ
90,32 մլրդ
Income tax expense
10,90 մլրդ
12,72 մլրդ
5,30 մլրդ
19,89 մլրդ
Effective tax rate
23,72%
28,04%
16,73%
22,03%
Other operating expenses
4,02 մլրդ
4,05 մլրդ
-9,05 մլրդ
-20,64 մլրդ
Net income
35,05 մլրդ
32,65 մլրդ
26,37 մլրդ
70,43 մլրդ
Net profit margin
12,75%
11,01%
8,78%
22,59%
Earnings per share
-
-
-
-
Interest and investment income
1,02 մլրդ
2,21 մլրդ
-
2,38 մլրդ
Interest expense
-18,00 մլն
-463,00 մլն
-1,32 մլրդ
-1,48 մլրդ
Net interest expenses
1,00 մլրդ
1,75 մլրդ
-1,32 մլրդ
905,00 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
66,76 մլրդ
69,98 մլրդ
79,07 մլրդ
116,67 մլրդ
Gain or loss from assets sale
4,72 մլրդ
154,00 մլն
188,00 մլն
12,00 մլն
AI content may include mistakes. Learn more
Google Apps